Navigation Links
EC 350 Paraffin Embedding Center

ProductsEC 350 Paraffin Embedding Center
Company MICROM International GmbH
Item EC 350 Paraffin Embedding Center
Features 
  • The EC 350 consists of two modular units: Cryo Console, and Dispensing Console
  • The Cryo Console features a large, non-stick surface and reaches a temperature of -15C
  • The Dispensing Console has a large paraffin reservoir, heated dispenser nozzle, heated work surface, heated forceps holder and cold spot
  • Includes separate heated compartments for molds and cassettes
  • The cassette compartment has a removable tray
  • This unit also features programmable operating times including automatic start
  • All heated surfaces are independently controlled, time programmable and easily monitored by an LC display
Description The EC 350 consists of two modular units. The Cryo Console features a large, non-stick surface and reaches a temperature of -15C. The Dispensing Console has a large paraffin reservoir, heated dispenser nozzle, heated work surface, heated forceps holder and cold spot. Includes separate heated compartments for molds and cassettes. The cassette compartment has a removable tray. This unit also features programmable operating times including automatic start. All heated surfaces are independently controlled, time programmable and easily monitored by an LC display.
Info MICROM International GmbH
Customer Service: +49 6227-836 0
Web site: http://www.microm.de

Related medicine products :

1. Shandon Slide and Paraffin Block Cabinets
2. Shandon Paraffin Block Cabinet
3. Shandon Paraffin Block Cartons
4. Paraffin Block Storage System
5. B-Cell Clonality Screening Assay by PCR, Paraffin
6. B-Cell & T-Cell Clonality Assessment by PCR, Paraffin
7. bcl-1/JH, t(11;14) Translocation by PCR, Paraffin
8. bcl-2/JH mbr Quantification, t(14;18) Translocation by PCR, Paraffin
9. bcl-2/JH, t(14;18) Translocation by PCR, Paraffin
10. C-erb B-2 (HER-2/neu) Tissue Assay, Paraffin
11. c-neu Tissue Assay, Paraffin
Other Medicine News:Health News:Ortho Organizers(R) Introduces Product Line Extension - Rectangular Super Elastic Nitanium(R) Black Ti(TM) Archwire 2Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 2Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 3Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 4Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 5Health News:Most ancient case of tuberculosis found in 500,000-year-old human; points to modern health issues 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 3Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 2Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 3Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 2Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 3
Breaking Medicine Technology:Al Novak Elected Chairman of the Board of OrbusNeich Medical 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 1Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 2Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 3Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 4Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 5Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 6Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 7Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 8Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 9Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 10Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 11Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 12Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 13Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 14Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 15Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 16Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 17Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 18Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 19Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 20Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 21Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics Market Forecasts to 2015 Competitive Benchmarking Product Pipeline an 62398 22Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 1PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately 2457 Million 15034 3